Literature DB >> 29248877

Fatty acid oxidation contributes to IL-1β secretion in M2 macrophages and promotes macrophage-mediated tumor cell migration.

Qi Zhang1, Herui Wang2, Chengyuan Mao2, Mitchell Sun2, Gifty Dominah2, Liyuan Chen3, Zhengping Zhuang4.   

Abstract

Tumor-associated macrophages (TAMs) are predominantly M2 phenotype in solid cancers including hepatocellular carcinoma (HCC). Though differentiation of M2 macrophages has been recently linked to fatty acid oxidation (FAO), whether FAO plays a role in functional maintenance of M2 macrophages is still unclear. Here, we used an in vitro model to mimic TAM-HCC interaction in tumor microenvironment. We found that M2 monocyte-derived macrophages (MDMs) enhanced the proliferation, migration, and invasion of HCC cells through an FAO-dependent way. Further investigations identified that IL-1β mediated the pro-migratory effect of M2 MDM. Using etomoxir and siRNA to inhibit FAO and palmitate to enhance FAO, we showed that FAO was responsible for the up-regulated secretion of IL-1β and, thus, the pro-migratory effect in M2 MDMs. In addition, we proved that IL-1β induction was reactive oxygen species and NLRP3-dependent. Our study demonstrates that FAO plays a key role in functional human M2 macrophages by enhancing IL-1β secretion to promote HCC cell migration. These findings provide evidence for different dependency of energy sources in macrophages with distinct phenotypes and functions, and suggest a novel strategy to treat HCC by reprogramming cell metabolism or modulating tumor microenvironment. Published by Elsevier Ltd.

Entities:  

Keywords:  Epithelial-to-mesenchymal transition; Inflammation; Metabolism; Tumor-associated macrophage; β-Oxidation

Mesh:

Substances:

Year:  2017        PMID: 29248877      PMCID: PMC5801116          DOI: 10.1016/j.molimm.2017.12.011

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  40 in total

1.  Macrophage-induced tumor angiogenesis is regulated by the TSC2-mTOR pathway.

Authors:  Wei Chen; Tao Ma; Xu-ning Shen; Xue-feng Xia; Guo-dong Xu; Xue-li Bai; Ting-bo Liang
Journal:  Cancer Res       Date:  2012-01-27       Impact factor: 12.701

2.  Hypoxia-inducible factor-1α/interleukin-1β signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment.

Authors:  Jingying Zhang; Qi Zhang; Yu Lou; Qihan Fu; Qi Chen; Tao Wei; Jiaqi Yang; Jinlong Tang; Jianxin Wang; Yiwen Chen; Xiaoyu Zhang; Jian Zhang; Xueli Bai; Tingbo Liang
Journal:  Hepatology       Date:  2018-03-26       Impact factor: 17.425

3.  Glycolysis regulates LPS-induced cytokine production in M2 polarized human macrophages.

Authors:  Sayako Chiba; Tadakazu Hisamatsu; Hiroaki Suzuki; Kiyoto Mori; Mina T Kitazume; Katsuyoshi Shimamura; Shinta Mizuno; Nobuhiro Nakamoto; Katsuyoshi Matsuoka; Makoto Naganuma; Takanori Kanai
Journal:  Immunol Lett       Date:  2017-01-24       Impact factor: 3.685

4.  Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling.

Authors:  Qi Zhang; Xueli Bai; Wei Chen; Tao Ma; Qida Hu; Chao Liang; Shangzhi Xie; Conglin Chen; Liqiang Hu; Shiguo Xu; Tingbo Liang
Journal:  Carcinogenesis       Date:  2013-01-27       Impact factor: 4.944

5.  Inflammatory cytokines augments TGF-beta1-induced epithelial-mesenchymal transition in A549 cells by up-regulating TbetaR-I.

Authors:  Xiangde Liu
Journal:  Cell Motil Cytoskeleton       Date:  2008-12

6.  M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway.

Authors:  Chao-Ying Liu; Juan-Ying Xu; Xiao-Yan Shi; Wei Huang; Ting-Yan Ruan; Ping Xie; Jun-Li Ding
Journal:  Lab Invest       Date:  2013-06-10       Impact factor: 5.662

7.  Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages.

Authors:  Evanna L Mills; Beth Kelly; Angela Logan; Ana S H Costa; Mukund Varma; Clare E Bryant; Panagiotis Tourlomousis; J Henry M Däbritz; Eyal Gottlieb; Isabel Latorre; Sinéad C Corr; Gavin McManus; Dylan Ryan; Howard T Jacobs; Marten Szibor; Ramnik J Xavier; Thomas Braun; Christian Frezza; Michael P Murphy; Luke A O'Neill
Journal:  Cell       Date:  2016-09-22       Impact factor: 41.582

8.  Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages.

Authors:  Stanley Ching-Cheng Huang; Bart Everts; Yulia Ivanova; David O'Sullivan; Marcia Nascimento; Amber M Smith; Wandy Beatty; Latisha Love-Gregory; Wing Y Lam; Christina M O'Neill; Cong Yan; Hong Du; Nada A Abumrad; Joseph F Urban; Maxim N Artyomov; Erika L Pearce; Edward J Pearce
Journal:  Nat Immunol       Date:  2014-08-03       Impact factor: 25.606

Review 9.  Metabolic reprograming in macrophage polarization.

Authors:  Silvia Galván-Peña; Luke A J O'Neill
Journal:  Front Immunol       Date:  2014-09-02       Impact factor: 7.561

10.  HBx regulates fatty acid oxidation to promote hepatocellular carcinoma survival during metabolic stress.

Authors:  Ming-Da Wang; Han Wu; Shuai Huang; Hui-Lu Zhang; Chen-Jie Qin; Ling-Hao Zhao; Gong-Bo Fu; Xu Zhou; Xian-Ming Wang; Liang Tang; Wen Wen; Wen Yang; Shan-Hua Tang; Dan Cao; Lin-Na Guo; Min Zeng; Meng-Chao Wu; He-Xin Yan; Hong-Yang Wang
Journal:  Oncotarget       Date:  2016-02-09
View more
  51 in total

Review 1.  Lipid Metabolism in Tumor-Associated Macrophages.

Authors:  Yuancai Xiang; Hongming Miao
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy.

Authors:  Jackie E Bader; Kelsey Voss; Jeffrey C Rathmell
Journal:  Mol Cell       Date:  2020-06-18       Impact factor: 17.970

3.  IL-1β promotes cervical cancer through activating NF-κB/CCL-2.

Authors:  Limin Tao; Sisun Liu; Juying Xiong; Huimin Yang; Yanfang Wu; Anli Xu; Yanfeng Gong
Journal:  Int J Clin Exp Pathol       Date:  2021-04-15

4.  Targeting hypoxia downstream signaling protein, CAIX, for CAR T-cell therapy against glioblastoma.

Authors:  Jing Cui; Qi Zhang; Qi Song; Herui Wang; Pauline Dmitriev; Mitchell Y Sun; Xiaoyu Cao; Yang Wang; Liemei Guo; Iris H Indig; Jared S Rosenblum; Chunxia Ji; Dongqing Cao; Kaiyong Yang; Mark R Gilbert; Yu Yao; Zhengping Zhuang
Journal:  Neuro Oncol       Date:  2019-11-04       Impact factor: 12.300

Review 5.  Lipids in the tumor microenvironment: From cancer progression to treatment.

Authors:  Kevin C Corn; McKenzie A Windham; Marjan Rafat
Journal:  Prog Lipid Res       Date:  2020-08-11       Impact factor: 16.195

6.  Interleukin-1β and cathepsin D modulate formation of the terminal complement complex in cultured human disc tissue.

Authors:  Graciosa Q Teixeira; Zhiyao Yong; Amelie Kuhn; Jana Riegger; Raquel M Goncalves; Michael Ruf; Uwe M Mauer; Markus Huber-Lang; Anita Ignatius; Rolf E Brenner; Cornelia Neidlinger-Wilke
Journal:  Eur Spine J       Date:  2021-06-24       Impact factor: 3.134

Review 7.  The role and therapeutic implication of CPTs in fatty acid oxidation and cancers progression.

Authors:  Junmin Wang; Hongjiao Xiang; Yifei Lu; Tao Wu; Guang Ji
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

Review 8.  The immunological and metabolic landscape in primary and metastatic liver cancer.

Authors:  Xin Li; Pierluigi Ramadori; Dominik Pfister; Marco Seehawer; Lars Zender; Mathias Heikenwalder
Journal:  Nat Rev Cancer       Date:  2021-07-29       Impact factor: 60.716

Review 9.  Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.

Authors:  Chunmei Fan; Shanshan Zhang; Zhaojian Gong; Xiayu Li; Bo Xiang; Hao Deng; Ming Zhou; Guiyuan Li; Yong Li; Wei Xiong; Zhaoyang Zeng; Xiaoling Li
Journal:  Sci China Life Sci       Date:  2020-08-17       Impact factor: 6.038

10.  S100A4 enhances protumor macrophage polarization by control of PPAR-γ-dependent induction of fatty acid oxidation.

Authors:  Shuangqing Liu; Huilei Zhang; Yanan Li; Yana Zhang; Yangyang Bian; Yanqiong Zeng; Xiaohan Yao; Jiajia Wan; Xu Chen; Jianru Li; Zhaoqing Wang; Zhihai Qin
Journal:  J Immunother Cancer       Date:  2021-06       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.